G&S Plots New Route to Medical Opinions

US healthcare specialist G&S Research has launched a new business unit - G&S Xchange - to provide access to key opinion leaders (KOLs) in the biopharmaceutical industry. The new unit will use medical meetings, rather than traditional MR methods, to get insights from influential yet hard-to-reach professionals.

The events, facilitated by G&S, will allow company executives to communicate directly with opinion leaders, and to discuss contingencies in scientific, medical, or regulatory areas that would be difficult to address through other methodologies.

The company says that KOLs rarely have time participate in focus groups or in-depth interviews, but 'are drawn to medical meetings for the opportunity to obtain new medical information and to interact with their peers'. It states that the educational environment of the meeting 'tends to break down barriers and generate rigorous discussion that is often more involved and frank than what emerges in traditional research settings'.

Gary Schwebach, a founding principal of G & S Research who is leading the G & S Xchange initiative, says the new division 'fills a critical gap in the biopharmaceutical industry. It addresses client information needs by applying systematic research methodologies to medical meetings.'

To help develop the new unit, the company has hired Luis Dominguez as Senior Manager for medical meetings. Dominguez has been providing business and financial consulting services since 1997 and served as president of the Hispanic Chamber of Commerce from 2000 through 2003.

The company is online at www.gs-research.com.

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• G&S Research
• All news